Biology subjects

Fackler, O. T.

Publications and source records attributed to Fackler, O. T..

3 recordsLinked to original sources

bioRxiv2022

Inferring cell motility in complex environments with incomplete tracking data

Cell motility has important influence on cell interactions and functionality for various biological aspects. Deciphering these dynamics often relies on live-cell microscopy measurements, which partly have to deal with limitations that could impair a reliable quantification of their motility. Especially given complex environments and tissue structures, limited observation periods, cells moving in and out of focus and impaired calibration of observation axes often lead to loss of cell tracks and insufficient tracking of motility within several dimensions. However, a reliable quantification of cell motility dynamics is essential when aiming at extrapolating the observed dynamics in order to understand cell population dynamics at larger temporal and spatial scales using appropriate simulation environments. To analyze how incomplete observations affect interpretation and parameterization of cell motility, we combined experimental observations with computational models. Studying individual cell dynamics within 3D collagen environments, we found that the gradual loss of cell tracks leads to an underestimation of several motility parameters with the effect dependent on the collagen density. By extending the automated fitting strategy FitMultiCell to account for cell track loss, we show that we are able to retrieve the actual cell dynamics and, thus, to reliably parameterize cell motility from such incomplete data. Applying our approach to the analysis of CD4+ T cells within 3D collagen environments that were infected with HIV-1, we could show that despite a considerable loss of cell tracks, the data still contained sufficient information to compare individual cell motilities by inferring and simulating their dynamics. Thereby, the analysis allowed us to disentangle the effect of HIV-1 infection and collagen density on individual cell motility. Our extended FitMultiCell-approach presented here provides a solution for the elimination of artifacts from cell track data analysis to robustly infer cell motility dynamics.

systems biology↗

bioRxiv2022

Temporal control of the integrated stress response by a stochastic molecular switch

Stress granules (SGs) are formed in the cytosol as an acute response to environmental cues and activation of the integrated stress response (ISR), a central signaling pathway controlling protein synthesis. Using chronic virus infection as stress model, we previously uncovered a unique temporal control of the ISR resulting in recurrent phases of SG assembly and disassembly. Here, we elucidate the molecular network generating this fluctuating stress response, by integrating quantitative experiments with mathematical modeling, and find that the ISR operates as a stochastic switch. Key elements controlling this switch are the cooperative activation of the stress-sensing kinase PKR, the ultrasensitive response of SG formation to the phosphorylation of the translation initiation factor eIF2, and negative feedback via GADD34, a stress-induced subunit of protein phosphatase 1. We identify GADD34 mRNA levels as the molecular memory of the ISR that plays a central role in cell adaptation to acute and chronic stress.

cell biology↗

bioRxiv2021

The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication

Combinations of direct-acting antivirals are needed to minimize drug-resistance mutations and stably suppress replication of RNA viruses. Currently, there are limited therapeutic options against the Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) and testing of a number of drug regimens has led to conflicting results. Here we show that cobicistat, which is an-FDA approved drug-booster that blocks the activity of the drug metabolizing proteins Cytochrome P450-3As (CYP3As) and P-glycoprotein (P-gp), inhibits SARS-CoV-2 replication. Cell-to-cell membrane fusion assays indicated that the antiviral effect of cobicistat is exerted through inhibition of spike protein-mediated membrane fusion. In line with this, incubation with low micromolar concentrations of cobicistat decreased viral replication in three different cell lines including cells of lung and gut origin. When cobicistat was used in combination with the putative CYP3A target and nucleoside analog remdesivir, a synergistic effect on the inhibition of viral replication was observed in cell lines and in a primary human colon organoid. The cobicistat/remdesivir combination was able to potently abate viral replication to levels comparable to mock-infected cells leading to an almost complete rescue of infected cell viability. These data highlight cobicistat as a therapeutic candidate for treating SARS-CoV-2 infection and as a potential building block of combination therapies for COVID-19.

microbiology↗